SEGMENT AND GEOGRAPHIC INFORMATION (Tables)

9 Months Ended

Sep. 30, 2018

Segment Reporting [Abstract]

Total Revenue By Major Geographic Area

Net sales and profit by reportable segment for the three and nine months ended September 30, 2018 and 2017 are as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2018			2017			2018		2017
	(In thousands)
Segment Net Sales
Codman Specialty Surgical	$	239,035		$	164,760		$	714,654	$	480,907
Orthopedics and Tissue Technologies	126,819			114,074			374,472		338,727
Total revenues	$	365,854		$	278,834		$	1,089,126	$	819,634
Segment Profit
Codman Specialty Surgical	$	91,871		$	68,289		$	272,480	$	198,242
Orthopedics and Tissue Technologies	35,515			30,411			105,094		88,500
Segment profit	127,386			98,700			377,574		286,742
Amortization	(5,268		)	(5,456)			(15,944)		(14,976)
Corporate and other	(98,441		)	(82,602		)	(284,740)		(234,180		)
Operating income	$	23,677		$	10,642		$	76,890	$	37,586

The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment.

The Company attributes revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2018		2017		2018		2017
	(In thousands)
United States	$	260,870	$	213,685	$	769,509	$	634,047
Europe	47,472		32,609		150,650		93,924
Asia Pacific	37,022		16,887		108,304		48,540
Rest of World	20,490		15,653		60,663		43,123
Total Revenues	$	365,854	$	278,834	$	1,089,126	$	819,634